Sunrest Lifescience Rights Issue 2026 Date, Price, Allotment, Ratio

Sunrest Lifescience Rights issue 2026 date is fixed, the rights issue is to open on April 2, 2026 and will close on April 30, 2026. The Sunrest Lifescience Rights issue 2026 record date is March 23, 2026. The company is to offer 42,91,200 equity shares at a price of ₹35 per share. The Sunrest Lifescience Rights issue 2026 size will be ₹15.02 Crores. The entitlement ratio is 1:1, 1 rights share for every 1 fully-paid equity shares held on the record date. Check out Sunrest Lifescience rights issue details.

IPO Watch

Sunrest Lifescience About us

Sunrest Lifescience, incorporated in 2017, is one of the leading companies that provides healthcare and personal care products to individuals. In the healthcare and personal care category, the firm offers capsules, tablets, syrups, ointments, gels, mouthwash, solutions, suspensions, dry powders, and toothpaste. 

The firm has a network of 43 manufacturers across Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand, and Madhya Pradesh. They provide a wide range of medicines to treat health issues, infections, diarrhea, fungal diseases, malaria, diabetes, allergies, blood pressure, as well as dental care products, cosmetics, vitamins, minerals, health supplements, and anti-inflammatory drugs.

Sunrest Lifescience Rights Issue Review

  • N/A

Sunrest Lifescience Rights Issue 2026 Dates & Time Table

Rights Issue Open:April 2, 2026
Rights Issue Close:April 30, 2026
Rights Record Date:March 23, 2026
Last Date to Buy Shares:March 20, 2026
Deemed Date of AllotmentMarch, 2026
Renunciation of Rights EntitlementsMarch 20, 2026

Sunrest Lifescience Rights Issue 2026 Offer Details

Rights Issue Size:Approx ₹15.02 Crores
Price Band:₹35 Per Equity Share
Face Value:₹10 Per Equity Share
Listing on:NSE
Entitlement Ratio: 1:1 (1 rights share for every 1 shares)
Equity:42,91,200 Equity Share
Letter of Offer:Click Here
Application Form:Click Here
Live Share Price:Click Here

Sunrest Lifescience Rights Issue 2026 Form & How to Apply

You can apply for Sunrest Lifescience Rights Issue 2026 in two ways:

  • Net Banking (ASBA)
  • Registrar’s Website (R-WAP Facility)

Sunrest Lifescience Financial Report

₹ in Crores
YearRevenueExpensePAT
2023₹24.67₹21.93₹2.04
2024₹29.48₹28.89₹0.23
2025₹33.12₹30.51₹2.00

Sunrest Lifescience Rights Issue 2026 Allotment Status

To Be Updated Soon

Sunrest Lifescience Rights Issue  2026 Lead Managers

  • To Be Updated Soon

Company Address:

Sunrest Lifescience Limited
6th Floor 608,
West Gate D-Block,
S G Highway, Makarba
Ahmedabad, 380051
Phone: 919925058245
Email: info@sunrestlifescience.com
Website: https://sunrestlifescience.com/

Sunrest Lifescience Rights Issue 2026 FAQs:


When is Sunrest Lifescience Rights Issue 2026 Record Date?

Sunrest Lifescience Rights Issue 2026 record date is March 23, 2026.

What is Sunrest Lifescience Rights Issue 2026 Price?

The company has fixed the price at ₹35 per equity share.

What is the Sunrest Lifescience Rights Issue 2026 Ratio?

The company has fixed the ratio (1:1), 1 Rights Equity Share for every 1 Equity Shares as on record date.

How to apply for Sunrest Lifescience Rights Issue 2026?

As per the record date you need to have Sunrest Lifescience Rights shares in your Demat account. You can participate in Rights Issue via offline form download or you can apply online via ASBA or UPI options.

Follow IPO Watch for the Upcoming IPO News and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *